BGM Group Ltd. is a US-listed company in the pharmaceuticals industry. Its financial year ends in September.
Loading chart…
Third-party market data · may be delayed
Under review: cash-flow, stock-pay or share-count figures missing or out of date.
Under review: cash-flow, stock-pay or share-count figures missing or out of date. We'll show the comparison once resolved.
BGM Group Ltd. valuation: adjust assumptions and compare models →
Revenue for the twelve months was $38m, up 51.1% on a year earlier, against a decline of 46.0% a quarter earlier. Free-cash-flow margin fell to -10.4% from -2.0% a year earlier. Operating margin narrowed to -33.2% from 4.2%. The diluted share count is up 1467.3% on a year earlier, which dilutes existing holders. It passes 2 of our 2 financial-health checks.
Our model value for BGM Group is under review, so past values are not shown until it is resolved.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
BGM Group Ltd.'s trailing-twelve-month revenue grew 51.1% year on year, with a free-cash-flow margin of -10.4%. Where it stands out: change in growth rate of +97.1pp ranks 2 of 74 pharmaceuticals companies we cover. Where it lags: change in share count of 1467.3% ranks 61 of 62 pharmaceuticals companies we cover.
Current signal Balance sheet growing far ahead of sales: Total assets grew 718% year over year while revenue grew 51% — the balance sheet is expanding 667 points faster than the business it supports.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for BGM from the sources we follow. See filings →
| At fiscal year end | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Share price | $588.07 | $173.22 | $118.05 | $239.70 | $307.20 |
| Market value | $60.1bn | $18.8bn | $12.8bn | $26.0bn | $34.8bn |
| + Net debt (− = net cash) | −$10m | −$14m | −$7m | −$10m | −$10m |
| Enterprise value | $60.1bn | $18.8bn | $12.8bn | $26.0bn | $34.8bn |
| Multiples | |||||
| Price / sales | n/m | n/m | n/m | n/m | n/m |
| Price / earnings | n/m | n/m | — | — | — |
| Price / free cash flow | — | n/m | n/m | n/m | — |
| EV / EBITDA | n/m | n/m | — | n/m | — |
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
No analyst estimates are published for BGM Group Ltd.: too few analysts cover it.
| Calendar year | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|
| Return | |||||
| BGM | −72% | +8% | +119% | −56% | −91% |
| Industry peers (median) | −49% | −14% | −2% | +9% | −12% |
| S&P 500 | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | |||||
| BGM | 25% | 17% | 58% | 42% | 27% |
| S&P 500 | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | |||||
| BGM | −72% | −79% | −47% | −77% | −94% |
| S&P 500 | −25% | −10% | −8% | −19% | −9% |
Worst fall since January 12, 2021: 100% from January 13, 2021 to September 25, 2026. Getting back needed a 24201% gain, and the shares have not yet recovered.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY18 Q4 | $50.4M |
| FY19 Q4 | $46.1M |
| FY20 Q4 | $50M |
| FY21 Q4 | $57.1M |
| FY22 Q4 | $64.9M |
| FY23 Q4 | $46.5M |
| FY24 Q4 | $25.1M |
| FY25 Q4 | $37.9M |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY19 Q4 | -8.5% |
| FY20 Q4 | 8.5% |
| FY21 Q4 | 14.1% |
| FY22 Q4 | 13.6% |
| FY23 Q4 | -28.3% |
| FY24 Q4 | -46.0% |
| FY25 Q4 | 51.1% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY18 Q4 | 11.9% |
| FY19 Q4 | 13.4% |
| FY20 Q4 | 9.6% |
| FY21 Q4 | 4.2% |
| FY22 Q4 | 3.2% |
| FY23 Q4 | -5.6% |
| FY24 Q4 | -2.2% |
| FY25 Q4 | -33.2% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY18 Q4 | 6.6% |
| FY19 Q4 | -2.6% |
| FY20 Q4 | 9.2% |
| FY21 Q4 | -2.0% |
| FY22 Q4 | 16.4% |
| FY23 Q4 | 0.3% |
| FY24 Q4 | 1.2% |
| FY25 Q4 | -10.4% |
| Fiscal year | 2018 Sept 2018 | 2019 Sept 2019 | 2020 Sept 2020 | 2021 Sept 2021 | 2022 Sept 2022 | 2023 Sept 2023 | 2024 Sept 2024 | 2025 Sept 2025 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 50 | 46 | 50 | 57 | 65 | 46 | 25 | 38 |
| Gross profit | 8 | 10 | 8 | 6 | 6 | 2 | 4 | 6 |
| EBITDA | 7 | 7 | 6 | 4 | 3 | −1 | 1 | −11 |
| Operating income | 6 | 6 | 5 | 2 | 2 | −3 | −1 | −13 |
| Net income | 5 | 6 | 5 | 3 | 1 | −8 | −1 | −20 |
| Diluted EPS | $0.06 | $0.06 | $0.06 | $0.03 | $0.01 | −$0.07 | −$0.01 | −$0.18 |
| Growth (year on year) | ||||||||
| Revenue | — | −8.5% | +8.5% | +14.1% | +13.6% | −28.3% | −46.0% | +51.1% |
| EBITDA | — | +2.0% | −19.7% | −39.3% | −7.3% | −144.1% | — | <−999% |
| Operating income | — | +3.5% | −22.1% | −50.4% | −12.0% | −224.2% | — | — |
| Net income | — | +13.6% | −14.3% | −37.7% | −65.9% | — | — | — |
| Diluted EPS | — | +5.9% | −5.6% | −47.1% | −66.7% | — | — | — |
| Margins | ||||||||
| Gross margin | 16.1% | 21.0% | 15.1% | 9.9% | 9.6% | 3.8% | 16.4% | 16.6% |
| EBITDA margin | 14.3% | 16.0% | 11.8% | 6.3% | 5.1% | −3.2% | 2.7% | −29.3% |
| Operating margin | 11.9% | 13.4% | 9.6% | 4.2% | 3.2% | −5.6% | −2.2% | −33.2% |
| Net margin | 10.3% | 12.8% | 10.1% | 5.5% | 1.7% | −16.7% | −5.7% | −52.6% |
| Free-cash-flow margin | 6.6% | −2.6% | 9.2% | −2.0% | 16.4% | 0.3% | 1.2% | −10.4% |
| Cash flow | ||||||||
| Cash from operations | 4 | −1 | 5 | 0 | 13 | 0 | 1 | −2 |
| Capital spending | 1 | 1 | 0 | 1 | 2 | 0 | 0 | 2 |
| Free cash flow | 3 | −1 | 5 | −1 | 11 | 0 | 0 | −4 |
| Stock-based pay | — | — | — | — | 0 | — | — | 10 |
| Free cash flow after stock pay | — | — | — | — | 11 | — | — | −14 |
| Balance sheet | ||||||||
| Cash | 6 | 5 | 12 | 10 | 14 | 7 | 10 | 10 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative = net cash) | −6 | −5 | −12 | −10 | −14 | −7 | −10 | −10 |
| Diluted shares | 90m | 90m | 90m | 102m | 108m | 108m | 108m | 113m |
| Returned to shareholders | ||||||||
| Dividends | 1 | — | — | — | — | 2 | — | — |
| Total returned | 1 | — | — | — | — | 2 | — | — |
| Last 12 months unless stated | BGM | IMCC | CPIX | SBFM | SCLX | BFRI | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $38m | $39m | $40m | $35m | $32m | $46m | $276m |
| Revenue growth, last 12 months | 51.1% | −0.7% | −5.2% | −2.7% | −28.5% | 17.8% | 9.9% |
| Revenue growth, 3-year average | — | — | −0.6% | 34.5% | −12.0% | 16.7% | 5.5% |
| Revenue growth, latest quarter | — | — | −18.8% | −1.6% | −22.8% | 32.9% | 6.5% |
| Gross margin | 16.6% | 17.7% | 82.9% | 30.3% | 55.5% | — | 62.0% |
| Operating margin | −33.2% | −21.2% | −24.1% | −16.6% | <−999% | −14.2% | −5.9% |
| Operating margin, 3-year average | — | — | −19.0% | −16.5% | −512.2% | −36.6% | −7.4% |
| Net margin | −52.6% | −20.7% | −27.4% | −16.5% | <−999% | −13.8% | −7.3% |
| Cash from operations / revenue | −6.3% | 8.6% | 1.9% | −15.1% | −54.1% | −17.2% | 10.2% |
| Free-cash-flow margin | −10.4% | 8.6% | 1.7% | −15.2% | −70.7% | −17.2% | 8.6% |
| Free-cash-flow margin, 3-year average | — | — | 5.4% | −25.5% | −2.8% | −31.6% | 7.4% |
| Stock pay / revenue | 27.0% | 0.0% | 1.1% | — | 51.0% | 2.4% | 3.6% |
| Change in share count | >999% | 71.3% | 1.5% | 55.7% | — | — | 1.9% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 51.1% | 10.0% | 10 of 74 |
| Change in growth rate Growth | +97.1pp | -0.3pp | 2 of 74 |
| Gross margin Profitability | 16.6% | 59.8% | 55 of 59 |
| Operating margin Profitability | -33.2% | -5.9% | 49 of 67 |
| Net margin Profitability | -52.6% | -7.3% | 59 of 75 |
| Free-cash-flow margin Cash generation | -10.4% | 10.1% | 55 of 74 |
| Stock pay as % of revenue Cash generation | 27.0% | 3.6% | 62 of 69 |
| Change in share count Balance sheet | 1467.3% | 1.5% | 61 of 62 |
| Days sales outstanding Balance sheet | 41 days | 72 days | 8 of 59 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Geode Capital Management, LLC | $36,198 | 98K | 26.0% | ▲ 109.7% |
| Xtx Topco Ltd | $23,192 | 63K | 16.7% | ▲ 451.6% |
| UBS Group AG | $21,214 | 58K | 15.2% | ▲ 2853.2% |
| Jane Street Group, LLC | $21,036 | 57K | 15.1% | New |
| Virtu Financial LLC | $20,000 | 54K | 14.4% | New |
| Susquehanna International Group, LLP | $11,788 | 32K | 8.5% | ▲ 103.8% |
| Ground Swell Capital, LLC | $4,081 | 11K | 2.9% | New |
| Royal Bank Of Canada | $1,000 | 1K | 0.7% | ▼ 25.3% |
| Jpmorgan Chase & Co | $681 | 2K | 0.5% | ▼ 8.5% |
| Morgan Stanley | $74 | 0K | 0.1% | 0.0% |
| Sbi Securities Co., Ltd. | $3 | 0K | 0.0% | ▲ 200.0% |
| Rockefeller Capital Management L.P. | $2 | 0K | 0.0% | 0.0% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not BGM Group Ltd.'s complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
